{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "7994569",
  "DateCompleted": {
    "Year": "1995",
    "Month": "01",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "09",
    "Day": "14"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0969-2126",
      "JournalIssue": {
        "Volume": "2",
        "Issue": "8",
        "PubDate": {
          "Year": "1994",
          "Month": "Aug",
          "Day": "15"
        }
      },
      "Title": "Structure (London, England : 1993)",
      "ISOAbbreviation": "Structure"
    },
    "ArticleTitle": "Structure-based drug design of antirhinoviral compounds.",
    "Pagination": {
      "StartPage": "695",
      "EndPage": "698",
      "MedlinePgn": "695-8"
    },
    "Abstract": {
      "AbstractText": [
        "Improved knowledge of rhinovirus structures makes it possible to identify three promising targets for broad-spectrum antirhinoviral drugs."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Sterling Winthrop Pharmaceuticals Research Division, Collegeville, PA 19426-0900."
          }
        ],
        "LastName": "Giranda",
        "ForeName": "V L",
        "Initials": "VL"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Structure",
    "NlmUniqueID": "101087697",
    "ISSNLinking": "0969-2126"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Capsid Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Receptors, Virus"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "metabolism",
        "pharmacology"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "Capsid"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Capsid Proteins"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Design"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism"
      ],
      "DescriptorName": "Receptors, Virus"
    },
    {
      "QualifierName": [
        "drug effects",
        "metabolism",
        "ultrastructure"
      ],
      "DescriptorName": "Rhinovirus"
    }
  ],
  "NumberOfReferences": "36"
}